GPCR/G protein

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-   B7345 Oxprenolol hydrochlorideSummary: β-adrenergic inhibitor B7345 Oxprenolol hydrochlorideSummary: β-adrenergic inhibitor
-   B6713 SB 221284Summary: 5-HT2C/2B receptor antagonist B6713 SB 221284Summary: 5-HT2C/2B receptor antagonist
-   B7343 Rec 15/2615 dihydrochlorideSummary: α1B-adrenoceptor antagonist B7343 Rec 15/2615 dihydrochlorideSummary: α1B-adrenoceptor antagonist
-   B6709 SB 228357Summary: 5-HT2C/2B receptor antagonist B6709 SB 228357Summary: 5-HT2C/2B receptor antagonist
-   B7232 DSP-4Summary: Adrenergic neurotoxin B7232 DSP-4Summary: Adrenergic neurotoxin
-   B6708 SB 204741Summary: 5-HT2B receptor antagonist B6708 SB 204741Summary: 5-HT2B receptor antagonist
-   B7226 Atipamezole hydrochlorideSummary: α2-adrenergic receptor antagonist B7226 Atipamezole hydrochlorideSummary: α2-adrenergic receptor antagonist
-   B6688 GR 113808Summary: 5-HT4 receptor antagonist B6688 GR 113808Summary: 5-HT4 receptor antagonist
-   B7194 Alprenolol hydrochlorideSummary: β-adrenoceptor and 5-HT1A receptor antagonist. B7194 Alprenolol hydrochlorideSummary: β-adrenoceptor and 5-HT1A receptor antagonist.
-   B6685 CP 94253 hydrochlorideSummary: 5-HT1B agonist B6685 CP 94253 hydrochlorideSummary: 5-HT1B agonist
